Clinical Trial Update: Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass [NA]

View source ↗

Summary

This completed clinical trial evaluated whether administering inhaled nitric oxide during neonatal cardiopulmonary bypass reduces ischemia/reperfusion injury an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Ischemia/Reperfusion Injury After Neonatal Cardiac Surgery, Inflammatory Reaction After Neonatal Cardiac Surgery | NA | Status: COMPLETED | Results posted: 2020-04-03